We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Lunglife Ai Inc | LSE:LLAI | London | Ordinary Share | ORD USD0.0001 (DI) |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.15 | -11.11% | 1.20 | 95,000 | 16:40:34 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 1.10 | 1.40 | 1.35 | 1.25 | 1.35 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:40:34 | UT | 20,000 | 1.20 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 10/2/2025 | 07:00 | UK RNS | LungLife AI, INC Change of Nominated Adviser and Joint Broker |
| 03/2/2025 | 12:31 | ALNC |  LungLife AI shares collapse as it plots AIM exit and potential wind-up |
| 03/2/2025 | 07:00 | UK RNS | LungLife AI, INC Operational Update & Proposed Cancellation |
| 19/11/2024 | 07:00 | UK RNS | LungLife AI, INC Operational update |
| 15/11/2024 | 07:00 | UK RNS | LungLife AI, INC Block listing Interim Review |
| 25/10/2024 | 06:00 | UK RNS | LungLife AI, INC Directorate Change |
| 22/10/2024 | 06:00 | UK RNS | LungLife AI, INC Cancellation & Reissue Share Options, PDMR Notice |
| 04/10/2024 | 06:00 | UK RNS | LungLife AI, INC Options Cancellation and Re-issuance |
| 02/10/2024 | 06:00 | UK RNS | LungLife AI, INC LungLB® publication in peer-reviewed journal |
| 02/9/2024 | 06:00 | UK RNS | LungLife AI, INC Data Supporting LungLB to be Presented at the AMP |
Lunglife Ai (LLAI) Share Charts1 Year Lunglife Ai Chart |
|
1 Month Lunglife Ai Chart |
Intraday Lunglife Ai Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 11/2/2025 | 12:19 | LungLife AI - ground breaking lung cancer diagnostics | 120 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 22/1/2025 11:16 by darmz This was 8p on Monday so some may take profits off and as it's so illiquid the price could fall even faster |
Posted at 22/1/2025 10:47 by findingways100 wish you told me about exr yesterday |
Posted at 22/1/2025 10:45 by tomboyb There are not too many AI stocks out there-Today took a stake in EXR - LLAI went nutx a while back from 20p and smashed to around 130p - However the point is look for ai stocks for portfolio - |
Posted at 11/3/2024 13:25 by joseph moran The spread is really small at the moment. The system will not let me sell, the traders have to execute the order.However I can buy for £0.289 the quoted sell price is £0.284 Never known such a small spread on this stock. |
Posted at 07/3/2024 16:36 by ohisay PI's look like they are out of the loop .Unless that changes the share price is fathomless. |
Posted at 02/1/2024 08:25 by brummy_git LungLife's patented Circulating Tumour Cell blood test (LungLB) successfully passes its pivotal 425 person, 17 site, validation study (commenced Feb’22) with flying colours.All the details here. |
Posted at 29/12/2023 08:23 by adorling About time Management put out an RNS to say they expect to release trial results soon to stop this relentless decline. The only positive is when they do publish them the illiquidity will drive the price up very steeply as people scramble to get back in having sold out previously. It went from just over 22p to 120p last time so I would settle for a 6-bag on good news! |
Posted at 29/12/2023 08:22 by adorling What chance of news in the next few weeks? |
Posted at 21/12/2023 06:58 by hatfullofsky They would release the results (which I expect to mirror the earlier study results) before any raise as that would generate lots more interest. Price may spike but it would be a discounted placing on the spiked price, probably around these levels.I do agree that it is an illiquid stock, which is only available on certain platforms. |
Posted at 20/12/2023 17:23 by donk7 Birmingham, has your pal Justin been knocking these out recently? Justin is an impressive small-cap stock picker but incredibly opaque regarding his buys, sells and trading intentions. I'm not sure that is the right way for someone who promotes his often illiquid stocks so forcefully. You can't get much more illiquid than LLAI.The issue with LungLife is that they will need to raise funds. That's no secret. It's not an easy market to do that and I'd assume those willing to fund will only want to come in before results rather than after a potential decent rise post positive results. No guarantees the results will be good but I'd imagine they would be decent. So my guess is a placing followed by results. I don't hold as it is too illiquid but it's one to watch. If they do a placing then hopefully that will make it less liquid. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
